Biosafety and Biosecurity in European Containment Level 3 Laboratories: Focus on French Recent Progress and essential Requirements

被引:15
作者
Pastorino, Boris [1 ,2 ]
de lamballerie, Xavier [1 ,2 ]
Charrel, Remi [1 ,2 ]
机构
[1] EPV Aix Marseille Univ, IHU Mediterranee Infect, UMR Emergence Pathol Virales, IRD 190,Inserm 1207,EHESP, Marseille, France
[2] Inst Hosp Univ Mediterranee Infect, APHM Publ Hosp Marseille, UMR Emergence Pathol Virales 190, Fac Med Timone, 19-21 Bd Jean Moulin, Marseille, France
关键词
biosafety; BSL-3; European union; regulations; infectious disease transmission; vertical; containment level 3; France; ACQUIRED INFECTIONS;
D O I
10.3389/fpubh.2017.00121
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Even if European Union (EU) Member States are obliged to implement EU Directives 2000/54/EC on the protection of workers from risks related to exposure to biological agents at work, national biosafety regulations and practices varied from country to country. In fact, EU legislation on biological agents and genetically modified microorganisms is often not specific enough to ensure harmonization leading to difficulties in implementation for most laboratories. In the same way, biosecurity is a relatively new concept and a few EU Member States are known to have introduced national laboratory biosecurity legislation. In France, recent regulations have reinforced biosafety/biosecurity in containment level 3 (CL-3) laboratories but they concern a specific list of pathogens with no correlation in other European Members States. The objective of this review was to summarize European biosafety/biosecurity measures concerning CL-3 facilities focusing on French specificities. Essential requirements needed to preserve efficient biosafety measures when manipulating risk group 3 biological agents are highlighted. In addition, International, European and French standards related to containment laboratory planning, operation or biosafety equipment are described to clarify optimal biosafety and biosecurity requirements.
引用
收藏
页数:11
相关论文
共 27 条
[1]  
[Anonymous], 2020, BIOSAFETY MICROBIOLO
[2]  
[Anonymous], 2012, BIOSECURITY CHALLENG
[3]   Poliovirus Studies during the Endgame of the Polio Eradication Program [J].
Arita, Minetaro .
JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2017, 70 (01) :1-6
[4]   State-of-the-Art in Biosafety and Biosecurity in European Countries [J].
Bielecka, Anna ;
Mohammadi, Ali Akbar .
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2014, 62 (03) :169-178
[5]  
Butaye P., 2013, Working in biosafety level 3 and 4 laboratories: a practical introduction, P59
[6]  
CEN (European Committee for Standardization), 2008, 15793 CWA CEN
[7]  
Centers for Disease Control and Prevention (CDC) Department of Health and Human Services (HHS), 2017, Fed Regist, V82, P6278
[8]   Biological risks and laboratory-acquired infections: a reality that cannot be ignored in health biotechnology [J].
Coelho, Ana Claudia ;
Diez, Juan Garcia .
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2015, 3
[9]  
Crane JT, 1999, J AM BIOL SAF ASS, V4, P17, DOI DOI 10.1177/109135059900400106
[10]   The hidden face of academic researches on classified highly pathogenic microorganisms [J].
Devaux, Christian A. .
INFECTION GENETICS AND EVOLUTION, 2015, 29 :26-34